126(top 1%)
papers
3.1K(top 1%)
citations
30(top 1%)
h-index
55(top 1%)
g-index
129
all documents
3.4K
doc citations
970
citing journals

Top Articles

#TitleJournalYearCitations
1Diverse and Targetable Kinase Alterations Drive Histiocytic NeoplasmsCancer Discovery2016372
2Deregulation of DUX4 and ERG in acute lymphoblastic leukemiaNature Genetics2016231
3COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL CampusLeukemia2020198
4Recurrent RAS and PIK3CA mutations in Erdheim-Chester diseaseBlood2014197
5DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodelingNature Medicine2016195
6Pathogenesis and management of iron toxicity in thalassemiaAnnals of the New York Academy of Sciences2010125
7Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencingNature Medicine2021118
8Iron deficiency anemia at admission for labor and delivery is associated with an increased risk for Cesarean section and adverse maternal and neonatal outcomesTransfusion2015107
9Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remissionBlood Advances201989
10Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell LeukemiaCancer Discovery202183
11Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular TherapyBiology of Blood and Marrow Transplantation201977
12The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemiaBlood Advances201971
13Objectives and Mechanism of Iron Chelation TherapyAnnals of the New York Academy of Sciences200568
14Survival following allogeneic transplant in patients with myelofibrosisBlood Advances202063
15Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter studyAmerican Journal of Hematology201359
16Severe and persistent heparin‐induced thrombocytopenia despite fondaparinux treatmentAmerican Journal of Hematology201559
17Molecular classification improves risk assessment in adult BCR-ABL1–negative B-ALLBlood202159
18Inhaled medicinal cannabis and the immunocompromised patientSupportive Care in Cancer201554
19Mechanism of Iron ToxicityFood and Nutrition Bulletin200747
20Autologous transplant remains the preferred therapy for relapsed APL in CR2Bone Marrow Transplantation201646
21Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysisCancer201645
22Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic LeukemiaBiology of Blood and Marrow Transplantation201741
23All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129Leukemia Research201340
24Single-agent dabrafenib for BRAF V600E -mutated histiocytosisHaematologica201840
25Impact of Pretransplantation 18F-fluorodeoxy Glucose–Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin LymphomaBiology of Blood and Marrow Transplantation201539
26Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in AdultsCurrent Oncology Reports201638
27Geography, ethnicity and “roots” in chronic lymphocytic leukemiaLeukemia and Lymphoma201337
28Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemiaBlood Advances201835
29Iron loading and its clinical implicationsAmerican Journal of Hematology200733
30Iron Deficiency, <i>Helicobacter</i> Infection and GastritisActa Haematologica200931
31High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcomeLeukemia201430
32Venetoclax is safe and efficacious in relapsed/refractory AMLLeukemia and Lymphoma202030
33Acute myeloid leukemia with translocation t(8;16) presents with features which mimic acute promyelocytic leukemia and is associated with poor prognosisLeukemia Research201329
34Clinical considerations and key issues in the management of patients with Erdheim-Chester Disease: a seven case seriesBMC Medicine201429
35Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?Genes Chromosomes and Cancer201628
36North American Leukemia, Intergroup Phase III Randomized Trial of Single Agent Clofarabine As Induction and Post-Remission Therapy, and Decitabine As Maintenance Therapy in Newly-Diagnosed Acute Myeloid Leukemia in Older Adults (Age ≥60 Years): A Trial of the ECOG-ACRIN Cancer Research Group (E2906)Blood201528
37Iron chelation therapyPsychophysiology200528
38Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemiaHaematologica201826
39The risk of tuberculosis in cancer patients is greatest in lymphoma and myelodysplastic syndrome/myeloproliferative neoplasm: a large population-based cohort studyLeukemia and Lymphoma201924
40Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the “3 + 7” induction regimen for acute myeloid leukemiaAmerican Journal of Hematology201522
41Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations for New Diagnostic CriteriaClinical Lymphoma, Myeloma and Leukemia201622
42Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B‐cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood LeukemiaPediatric Blood and Cancer201922
43Familial hemophagocytic lymphohistiocytosis in Israel: II. Pathologic findingsCancer198421
44A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult diseaseAmerican Journal of Hematology201921
45Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research StudyBiology of Blood and Marrow Transplantation202021
46Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practiceAmerican Journal of Hematology202120
47Higher Infection Rate After 7- Compared With 5-Day Cycle of Azacitidine in Patients With Higher-Risk Myelodysplastic SyndromeClinical Lymphoma, Myeloma and Leukemia201518
48Perspectives on current survival and new developments in AMLBest Practice and Research in Clinical Haematology202115
49Acute lymphoblastic leukemia displays a distinct highly methylated genomeNature Cancer202215
50Primary plasma cell leukemia in the era of novel agents for myeloma – a multicenter retrospective analysis of outcomeLeukemia Research201814